Bioventix PLC (AIM: BVXP)

Bioventix Balance Sheet

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	6	6	5.72	6.13	6.49	8.08
Cash & Short-Term Investments	6	6	5.72	6.13	6.49	8.08
Cash Growth	4.95%	4.95%	-6.71%	-5.67%	-19.58%	23.54%
Accounts Receivable	1.52	1.52	1.17	0.75	0.64	0.64
Other Receivables	0.03	0.03	0	0.01	0.01	0.01
Receivables	1.55	1.55	1.17	0.76	0.65	0.64
Inventory	0.62	0.62	0.57	0.46	0.33	0.25
Prepaid Expenses	4.66	4.66	4.64	4.46	3.98	3
Total Current Assets	12.83	12.83	12.1	11.81	11.45	11.97
Property, Plant & Equipment	0.48	0.48	0.58	0.69	0.84	0.72
Long-Term Investments	0.43	0.43	0.61	0.61	0.61	0.61
Total Assets	13.73	13.73	13.28	13.12	12.91	13.3
Accounts Payable	0.17	0.17	0.08	0.16	0.15	0.1
Accrued Expenses	0.4	0.4	0.41	0.39	0.32	0.31
Current Income Taxes Payable	1.15	1.15	0.71	0.71	0.54	0.32
Total Current Liabilities	1.73	1.73	1.2	1.25	1.01	0.73
Long-Term Deferred Tax Liabilities	-	-	0.02	0.04	0.08	0.05
Total Liabilities	1.73	1.73	1.22	1.3	1.09	0.78
Common Stock	0.26	0.26	0.26	0.26	0.26	0.26
Additional Paid-In Capital	1.47	1.47	1.47	1.33	1.33	1.31
Retained Earnings	10.27	10.27	10.33	10.23	10.23	10.95
Comprehensive Income & Other	0	0	0	0	0	0
Shareholders' Equity	12	12	12.06	11.82	11.82	12.52
Total Liabilities & Equity	13.73	13.73	13.28	13.12	12.91	13.3
Net Cash (Debt)	6	6	5.72	6.13	6.49	8.08
Net Cash Growth	4.95%	4.95%	-6.71%	-5.67%	-19.58%	23.54%
Net Cash Per Share	1.13	1.13	1.08	1.16	1.23	1.55
Filing Date Shares Outstanding	5.22	5.22	5.22	5.21	5.21	5.21
Total Common Shares Outstanding	5.22	5.22	5.22	5.21	5.21	5.21
Working Capital	11.1	11.1	10.9	10.56	10.44	11.24
Book Value Per Share	2.30	2.30	2.31	2.27	2.27	2.40
Tangible Book Value	12	12	12.06	11.82	11.82	12.52
Tangible Book Value Per Share	2.30	2.30	2.31	2.27	2.27	2.40
Machinery	0.96	0.96	0.94	0.93	1.08	0.83

Source: S&P Capital IQ. Standard template. Financial Sources.